Buy Idebenone Bulk Powder Pure Nootropics Cognitive Enhancer Online For Alzheimer’s disease CAS 58186-27-9
What is Idebenone?
Idebenone is a man-made product similar to coenzyme Q-10.
Idebenone is used for Alzheimer’s disease, liver disease, and heart disease; as well as a number of inherited disorders including Leber’s disease (an eye condition), mitochondrial encephalomyopathies (nerve and muscle disorders), and Friedreich’s ataxia (a nervous system disorder that worsens over time, producing gait and speech problems, and eventually leading toward heart disease and diabetes).
Idebenone Basic information
CAS No: 58186-27-9
Molecular formula: C19H30O5
Molecular weight: 338.44
EINECS: N/A
Assay: 99% min pure
Appearance: orange-yellow crystalline powder
Catalogue: Pharmaceutical materials;Health supplements;APIs;Brain health drug;Nootropic
Other Nootropics we offer: noopept;hydroxypiracetam;piracetam;Ferulic Acid;COLURACETAM…
Idebenone Certificate of Analysis
Product name |
Idebenone |
CAS No. |
58186-27-9 |
Outer Packing |
1kg/bag |
Production date |
21th Jan 2018 |
Shelf life |
20th Jan 2020 |
Standard Adopted |
Enterprise Standard |
Test Items |
Specifications |
Result |
Appearance |
An orange yellow or yellow,
crystalline powder |
Conforms |
Solubility |
Insoluble in water,very soluble in methanol,
chlorroform,freely soluble in anhydrous alcohol and ethyl acetate |
Conforms |
E1%1cm |
458~486 |
464 |
Melting Range |
52~55ºC |
53.3~53.7ºC |
Loss on Drying |
≤0.1% |
0.03% |
Residue on Ignition |
≤0.1% |
0.02% |
Heavy Metals |
≤10ppm |
Conforms |
Impurities(HPLC) |
≤0.8% |
0.50% |
Residue
Solvents(GC) |
Hexane≤0.029% |
Conforms |
Methanol≤0.3% |
Conforms |
Toluene≤0.089% |
Conforms |
Assay(HPLC) |
≥98.5%,
anhydrous substance |
99.50% |
Microorganism Limit |
TAMC≤1000cfu/g |
Absent |
TYMC≤100cfu/g |
Absent |
Packing and storage:Keep in a well-closed container,
stored at the temperature not exceeding 20ºC |
Idebenone Usage
Treating Alzheimer’s disease. There’s some evidence that taking idebenone slows the decline of thinking skills in people with Alzheimer’s disease. Idebenone appears most effective in patients with moderately severe Alzheimer’s disease.
Idebenone Effects
Idebenone has a metabolic and trophic effect. Increases the metabolic processes in the brain by activating the synthesis of glucose and ATP, improves blood circulation and oxygenation of brain tissue, promotes the excretion of lactate; increases the intensity and speed of neurophysiological responses of brain structures. Slowing lipid peroxidation, prevents neuronal membranes and mitochondria from damage. From the first days of use, it exhibits antiastenicheskoe, psychostimulant and antidepressant effects; nootropic effect manifests itself after 3-4 weeks of reception.
Idebenone has been shown to have anti-aging and antioxidant properties. This nootropic may promote the brain health longevity and stimulate nerve growth in most individuals. Over the years, this substance has been labeled to be a cognitive enhancing nootropic and/or an antioxidant.
IDEBENONE DOSAGE
The suggested dosage of Idebenone is usually 125-375 mg per day, taken as 125 mg individual dosages, one in the morning and one in the afternoon.